Eddit
| Zeile 7: | Zeile 7: | ||
*'''[[Reviews on covid19 disease]]''' | *'''[[Reviews on covid19 disease]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Clinical guidelines and advice]]''' | *'''[[Clinical guidelines and advice]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
---- | ---- | ||
| Zeile 32: | Zeile 15: | ||
*'''[[Structure of covid19]]''' | *'''[[Structure of covid19]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Target binding and uptake]]''' | *'''[[Target binding and uptake]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Cytopathic effects]]''' | *'''[[Cytopathic effects]]''' | ||
| Zeile 60: | Zeile 28: | ||
*'''[[Immunology]]''' | *'''[[Immunology]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| Zeile 81: | Zeile 33: | ||
*'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | ||
| − | |||
| − | |||
| − | |||
---- | ---- | ||
| Zeile 95: | Zeile 44: | ||
*'''[[Co-Infection]]''' | *'''[[Co-Infection]]''' | ||
| − | |||
| − | |||
| − | |||
| Zeile 103: | Zeile 49: | ||
*'''[[Pulmonary embolism, coagulation]]''' | *'''[[Pulmonary embolism, coagulation]]''' | ||
| − | |||
| − | |||
| Zeile 114: | Zeile 58: | ||
*'''[[Heart]]''' | *'''[[Heart]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Neurology, ophthalmology, orl]]''' | *'''[[Neurology, ophthalmology, orl]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| Zeile 141: | Zeile 67: | ||
*'''[[Gastroenterology, hepatology]]''' | *'''[[Gastroenterology, hepatology]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Kidney, urology]]''' | *'''[[Kidney, urology]]''' | ||
| − | |||
| − | |||
| − | |||
---- | ---- | ||
| Zeile 154: | Zeile 73: | ||
*'''[[Pathobiology]]''' | *'''[[Pathobiology]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| Zeile 163: | Zeile 78: | ||
*'''[[Similar diseases and pathomechanisms]]''' | *'''[[Similar diseases and pathomechanisms]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
---- | ---- | ||
| Zeile 174: | Zeile 83: | ||
*'''[[Diagnosis (Laboratory)]]''' | *'''[[Diagnosis (Laboratory)]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Diagnosis (Lung CT, Sonography)]]''' | *'''[[Diagnosis (Lung CT, Sonography)]]''' | ||
| − | |||
| − | |||
| − | |||
| Zeile 192: | Zeile 93: | ||
*'''[[Respiration mgmt]]''' | *'''[[Respiration mgmt]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Risk and special populations]]''' | *'''[[Risk and special populations]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
Version vom 28. Mai 2020, 22:59 Uhr
32311318 ä. SARS-CoV-2 and viral sepsis: observations and hypotheses
32325026 2020. Endothelial cell infection and endotheliitis in COVID-19
32304647 2020. SARS-CoV-2 shedding and infectivity
32304646 ä. SARS-CoV-2 shedding and infectivity ? Authors reply
32294340 ä. Immune Thrombocytopenic Purpura in a Patient with Covid-19
32344326 2020. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries
32219356 ä. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
32369030 2020. Considerations for Postacute Rehabilitation for Survivors of COVID-19
32333842 2020. The key role of palliative care in response to the COVID-19 tsunami of suffering
32224310 ä. Clinical and virological data of the first cases of COVID-19 in Europe: a case series
32164830 2020. COVID-19 with spontaneous pneumomediastinum
32229159 ä. SARS-CoV-2 infection presenting with hematochezia
32004427 2020. First Case of 2019 Novel Coronavirus in the United States
32220650 ä. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study
32087116 2020. Asymptomatic cases in a family cluster with SARS-CoV-2 infection
32105632 ä. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
32379729 2020. Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19 - Georgia, March 2020
32214079 2020. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020
32290644 2020. Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India
32227758 ä. Covid-19 in Critically Ill Patients in the Seattle Region ? Case Series
32302078 ä. Clinical Characteristics of Covid-19 in New York City
32332185 2020. Care for adult non-ICU Covid-19 patients: early experiences from a Belgian tertiary care centre
32305438 ä. The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19
32309814 ä. Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries
32242121 ä. The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic
32290293 2020. A Review of SARS-CoV-2 and the Ongoing Clinical Trials
32363333 ä. A real-time dashboard of clinical trials for COVID-19
C7158785 ä. Convalescent plasma: A possible treatment of COVID-19 in India
32217166 2020. Chloroquine and COVID-19, where do we stand??
32240719 ä. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
32353355 ä. Testosterone, a key hormone in the context of COVID-19 pandemic
32344177 2020. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect
32305500 ä. Chloroquine paradox may cause more damage than help fight COVID-19
32370766 2020. Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines
32307014 2020. Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19
32255312 2020. A possible probiotic (S salivarius K12) approach to improve oral and lung microbiotas and raise defenses against SARS-CoV-2
32365556 2020. Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-gamma as Candidates for Cytokine Storm Modulation in COVID-19 Disease
32316270 2020. COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help
32231349 2020. Chloroquine in COVID-19: the evidence
32231348 2020. Emerging prophylaxis strategies against COVID-19
32291351 2020. Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data
32187464 ä. A Trial of Lopinavir?Ritonavir in Adults Hospitalized with Severe Covid-19
32187463 ä. Covid-19 ? The Search for Effective Therapy
32275812 ä. Compassionate Use of Remdesivir for Patients with Severe Covid-19
32354113 2020. On Facing the SARS-CoV-2 (COVID-19) with Combination of Nanomaterials and Medicine: Possible Strategies and First Challenges
32326343 2020. Can Nanotechnology and Materials Science Help the Fight against SARS-CoV-2?
32366817 2020. A human monoclonal antibody blocking SARS-CoV-2 infection
32203437 ä. Insights from nanomedicine into chloroquine efficacy against COVID-19
32358580 ä. COVID-19: a case for inhibiting IL-17?
32358579 ä. Will helminth co-infection modulate COVID-19 severity in endemic regions?
32296135 ä. COVID-19: risk for cytokine targeting in chronic inflammatory diseases?
32355330 ä. Inactivated vaccine for SARS-CoV-2
32327719 ä. Complement as a target in COVID-19?
32346092 ä. Cancer therapy tool informs COVID-19 vaccines
32346094 ä. COVID-19 vaccine design: the Janus face of immune enhancement
32317716 ä. The potential danger of suboptimal antibody responses in COVID-19
32286538 ä. Human antibodies can neutralize SARS-CoV-2
32332922 ä. SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2
32327746 ä. Translating IL-6 biology into effective treatments
32341531 ä. Could BCG be used to protect against COVID-19?
32291449 ä. ADAM17 inhibition may exert a protective effect on COVID-19
32350818 ä. Chloroquine-induced QTc prolongation in COVID-19 patients
32303482 ä. Re-emergence of SARS-CoV2 in a discharged COVID-19 case
32299784 ä. How do we decide to de-isolate COVID-19 patients?
32105304 2020. Positive RT-PCR Test Results in Patients Recovered From COVID-19
32276848 ä. Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019
32224116 ä. Do children need a longer time to shed SARS-CoV-2 in stool than adults?
32035510 2020. 2019-nCoV transmission through the ocular surface must not be ignored
32199469 2020. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples
32214231 ä. COVID-19: faecal?oral transmission?
32340347 2020. Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough
32360356 ä. Putting some context to the aerosolization debate around SARS-CoV-2
32294374 ä. Droplets and Aerosols in the Transmission of SARS-CoV-2
32129805 2020. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient
32203710 2020. Rational use of face masks in the COVID-19 pandemic
32344688 2020. 3-D Printed Protective Equipment during COVID-19 Pandemic
32322988 ä. Umgang mit COVID-19 in der Notaufnahme: Erfahrungsbericht der interdisziplinären Notaufnahme des Universitätsklinikums Münster
32329322 2020. In considerations of robotic colorectal surgery within a COVID-19 pandemic
32327626 2020. Management of inflammatory bowel disease during COVID-19 pandemic
32225135 2020. Pathways for urology patients during the COVID-19 pandemic
32202401 2020. Urology practice during COVID-19 pandemic
32253371 2020. Impact of the COVID-19 pandemic on urology residency training in Italy
32368875 2020. Guide for Nuclear Medicine Applications During the COVID-19 Outbreak
32210421 2020. COVID-19 in intensive care Some necessary steps for health care workers
32297490 2020. COVID-19 pandemic: what consequences for cardiac rehabilitation?
32278860 2020. Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge
32335508 2020. One Aspect of Coronavirus disease (COVID-19) Outbreak in Iran: High Anxiety among MS Patients
32334820 2020. The COVID-19 pandemic and the use of MS disease-modifying therapies
31986242 2020. Medical Journals and the 2019-nCoV Outbreak
32329975 ä. Covid-19 and Kidney Transplantation
32242095 ä. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic
32341524 ä. Cancer and COVID-19 ? potentially deleterious effects of delaying radiotherapy
32296166 ä. Provision of cancer care during the COVID-19 pandemic
32214232 ä. Management of IBD during the COVID-19 outbreak: resetting clinical priorities
32249840 ä. Minimizing the risk of COVID-19 among patients on dialysis
32355296 ä. Combating physical inactivity during the COVID-19 pandemic
32340751 ä. Manejo de la epidemia por coronavirus SARS-CoV-2 (Covid 19) en unidades de hemodialisis
32278616 ä. Recomendaciones en el manejo de la pandemia por coronavirus SARS-CoV-2 (Covid-19) en pacientes con trasplante renal
32348989 2020. Infection Control Measures for COVID-19 in the Labour Suite and Neonatal Unit
32335559 2020. Neonatal Resuscitation Where the Mother Has a Suspected or Confirmed Novel Coronavirus (SARS-CoV-2) Infection: Suggestion for a Pragmatic Action Plan
32325458 2020. COVID-19 and Neonatal Resuscitation
32196116 ä. Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres
32339235 ä. A Quantitative Framework for Modeling COVID-19 Risk During Adjuvant Therapy Using Published Randomized Trials of Glioblastoma in the Elderly
32289798 ä. Clinical Trials during the SARS-CoV-2 Pandemic
32277236 ä. Urgent Considerations for the Neuro-oncologic Treatment of Patients with Gliomas During the COVID-19 Pandemic
32319670 2020. Telemedicine in neurosurgery during the novel coronavirus (COVID-19) pandemic
32363507 ä. Dealing with immune-mediated neuropathies during COVID-19 outbreak: practical recommendations from the task force of the Italian Society of Neurology (SIN), the Italian Society of Clinical Neurophysiology (SINC) and the Italian Peripheral Nervous System Association (ASNP)
32096116 2020. The Risk and Prevention of Novel Coronavirus Pneumonia Infections Among Inpatients in Psychiatric Hospitals
32361728 ä. Letter: The Resiliency of the Neurosurgeon in the Midst of COVID-19 Pandemic Storm: The Italian Experience From the Frontline
32358606 ä. Letter: Considerations for Performing Emergent Neurointerventional Procedures in a COVID-19 Environment
32336528 ä. La gesti�n de la asistencia neurol�gica en tiempos de la pandemia de COVID-19
32364119 ä. Influencia de la infecci�n SARS-CoV-2 sobre enfermedades neurodegenerativas y neuropsiqui�tricas: �una pandemia demorada?
32364117 ä. Un Servicio de Neurolog�a de un hospital terciario en la pandemia COVID-19
32355985 ä. Letter: Safety Instructions for Neurosurgeons During COVID-19 Pandemic Based on Recent Knowledge and Experience
32355982 ä. Letter: Back Pain and Accesses to Emergency Departments During COVID-19 Lockdown in Italy
32355962 ä. Letter: The Use of Absorbable Sutures in Neurosurgical Procedures in the Time of COVID-19
32355961 ä. Letter: COVID-19 Impact on the Medical Student Path to Neurosurgery
32355949 ä. Letter: Neurosurgical Patients? Management During the COVID-19 Pandemic?An Institutional Report From an African Neurosurgical Center
32242901 ä. Letter: The Coronavirus Disease 2019 Global Pandemic: A Neurosurgical Treatment Algorithm
32347942 ä. Letter: Surgical Management of Brain Tumor Patients in the COVID-19 Era
32343340 ä. Letter: Neurosurgical Management of Spinal Pathology Via Telemedicine During the COVID-19 Pandemic: Early Experience and Unique Challenges
32335684 ä. Letter: The Risk of COVID-19 Infection During Neurosurgical Procedures: A Review of Severe Acute Respiratory Distress Syndrome Coronavirus 2 (SARS-CoV-2) Modes of Transmission and Proposed Neurosurgery-Specific Measures for Mitigation
32335681 ä. Letter: Maintaining Neurosurgical Resident Education and Safety During the COVID-19 Pandemic
32335668 ä. Letter: COVID-19 Pandemic: Safety Precautions for Stereotactic Radiosurgery
32323725 ä. In Reply: Precautions for Endoscopic Transnasal Skull Base Surgery During the COVID-19 Pandemic
32310292 ä. Letter: Collateral Pandemic in Face of the Present COVID-19 Pandemic: A Neurosurgical Perspective
32304213 ä. Letter: COVID-19 Infection Affects Surgical Outcome of Chronic Subdural Hematoma
32304212 ä. Letter: Transmission of COVID-19 During Neurosurgical Procedures?Some Thoughts From the United Kingdom
32302399 ä. A COVID-19 Patient Who Underwent Endonasal Endoscopic Pituitary Adenoma Resection: A Case Report
32302398 ä. In Reply: Precautions for Endoscopic Transnasal Skull Base Surgery During the COVID-19 Pandemic
32302387 ä. Letter: Adaptation Under Fire: Two Harvard Neurosurgical Services During the COVID-19 Pandemic
32302385 ä. Letter: Rongeurs, Neurosurgeons, and COVID-19: How Do We Protect Health Care Personnel During Neurosurgical Operations in the Midst of Aerosol-Generation From High-Speed Drills?
32293678 ä. Letter: Precautions for Endoscopic Transnasal Skull Base Surgery During the COVID-19 Pandemic
32293677 ä. Letter: Neurosurgery and Coronavirus (COVID-19) Epidemic: Doing our Part
32277754 ä. Letter: Academic Neurosurgery Department Response to COVID-19 Pandemic: The University of Miami/Jackson Memorial Hospital Model
32277757 ä. Letter: Strategies for Prevention and Control of 2019 Novel Coronavirus Infection Among Medical Staff
32035030 2020. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus
32085839 2020. Mental health care for medical staff in China during the COVID-19 outbreak
32291383 2020. Psychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 2020 During the Outbreak of Coronavirus Disease 2019 (COVID-19) in Hubei, China
32221635 ä. Umgang mit psychischer Belastung bei Gesundheitsfachkräften im Rahmen der Covid-19-Pandemie
32294078 2020. Comparison of the Indicators of Psychological Stress in the Population of Hubei Province and Non-Endemic Provinces in China During Two Weeks During the Coronavirus Disease 2019 (COVID-19) Outbreak in February 2020
32283124 ä. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic
32305069 ä. Protecting workers aged 60?69 years from COVID-19
32219471 ä. Mutterschutz ? auch im Zeitalter der Coronakrise
32242087 ä. What the stock market tells us about the post-COVID-19 world
32236594 2020. Possibility of transmission through dogs being a contributing factor to the extreme Covid-19 outbreak in North Italy
31996413 2020. Discovery of Bat Coronaviruses through Surveillance and Probe Capture-Based Next-Generation Sequencing
32051570 2020. Novel coronavirus takes flight from bats?
32376697 2020. An Extensive Meta-Metagenomic Search Identifies SARS-CoV-2-Homologous Sequences in Pangolin Lung Viromes
32284615 ä. The proximal origin of SARS-CoV-2
32282789 2020. Public Health Interventions to Mitigate Early Spread of SARS-CoV-2 in Poland
32244041 2020. Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids
32088333 2020. Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases
32087334 2020. The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future
32278074 ä. Emergency response to the outbreak of COVID-19: the Korean case
32379733 2020. Public Health Response to the Initiation and Spread of Pandemic COVID-19 in the United States, February 24-April 21, 2020
32379731 2020. COVID-19 Among Workers in Meat and Poultry Processing Facilities - 19 States, April 2020
32352957 2020. Assessment of SARS-CoV-2 Infection Prevalence in Homeless Shelters - Four U S Cities, March 27-April 15, 2020
32134909 2020. Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 - United States, January-February 2020
32324720 2020. Cleaning and Disinfectant Chemical Exposures and Temporal Associations with COVID-19 ? National Poison Data System, United States, January 1, 2020?March 31, 2020
32298247 2020. Characteristics of Health Care Personnel with COVID-19 - United States, February 12-April 9, 2020
32265315 2020. 2019 Novel Coronavirus (COVID-19) Pandemic: Built Environment Considerations To Reduce Transmission
32003551 2020. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
31995857 2020. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus?Infected Pneumonia
32329972 ä. Asymptomatic Transmission, the Achilles? Heel of Current Strategies to Control Covid-19
32182409 ä. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
32289214 ä. Spread of SARS-CoV-2 in the Icelandic Population
32273611 ä. A framework for identifying regional outbreak and spread of COVID-19 from one-minute population-wide surveys
31988464 2020. China s response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response
32284619 ä. On the responsible use of digital data to tackle the COVID-19 pandemic
32284618 ä. Digital technology and COVID-19
32322102 ä. Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy
32257511 2020. COVID-19 Pandemic: Public Health Implications in Nepal
32221514 ä. How behavioural science data helps mitigate the COVID-19 crisis
32203324 ä. COVID-19 and the crisis of national development
32294342 ä. Death from Covid-19 of 23 Health Care Workers in China
32334040 ä. The fate of house cats during the COVID-19 pandemic
C7110433 ä. Coronaviren: von der banalen Erkältung zum schweren Lungenversagen: Chronologie einer Pandemie
32108160 2020. Emergence of a novel human coronavirus threatening human health
31988490 2020. Outbreak of a novel coronavirus
32015508 2020. A new coronavirus associated with human respiratory disease in China
32015507 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin
32203708 ä. COVID-19 outbreak: less stethoscope, more ultrasound
32192583 2020. COVID-19: delay, mitigate, and communicate
32344311 2020. 2019-nCoV-SARS-CoV-2 (COVID-19) infection: Cruc?al?ty of Fur?n and relevance w?th cancer
32360951 2020. The first Ramadan during COVID-19 pandemic: 1 8 billion Muslims should fast or not?
32368884 2020. Management of COVID-19: the risks associated with treatment are clear, but the benefits remain uncertain
C7144332 ä. On being human in the face of a pandemic
C7118609 ä. NetNCSP: Nonoverlapping closed sequential pattern mining
32365567 2020. Lab-on-a-Chip Technologies for the Single Cell Level: Separation, Analysis, and Diagnostics
- [[PrePrint scene
- prelights
- from the ads
- [lifechemicals.com antiviral candidate drugs]
- [biomol.com assays cytokines general spectrum]
- [labospace.com custom single probe assay 400 possible cytokines and so on]
- [codexdna.com dna synthesis]
- [eclipsebio.com around rna]
- [btbemulsions.com freud adjuvant kit]
- Current state of coviki.org
